兴齐眼药(300573) - 2024 Q1 - 季度财报

Financial Performance - Revenue for the first quarter of 2024 was RMB 349.88 million, a 22.10% increase compared to the same period last year[4] - Net profit attributable to shareholders of the listed company was RMB 34.75 million, a 79.59% increase year-on-year[4] - Total revenue for Q1 2024 reached 349.88 million yuan, a 22.1% increase compared to 286.56 million yuan in the same period last year[17] - Net profit for Q1 2024 was 34.75 million yuan, up 79.6% from 19.35 million yuan in Q1 2023[18] - Operating profit for Q1 2024 was 47.25 million yuan, more than double the 22.87 million yuan in Q1 2023[18] - Comprehensive income for the first quarter of 2024 totaled RMB 34,748,964.87, with RMB 34,748,964.87 attributable to the parent company[19] - Basic and diluted earnings per share for the first quarter of 2024 were both RMB 0.28[19] Cash Flow - Net cash flow from operating activities was RMB 83.44 million, up 43.03% compared to the same period last year[4] - Net cash flow from financing activities increased by 95.99% to RMB 29.21 million due to increased bank borrowings[10] - Cash received from sales of goods and services in the first quarter of 2024 was RMB 367,263,692.00, a 29.7% increase from RMB 283,170,181.44 in the same period last year[20] - Total cash inflows from operating activities in the first quarter of 2024 were RMB 379,055,539.89, a 32.0% increase from RMB 287,111,040.43 in the same period last year[20] - Cash paid for goods and services in the first quarter of 2024 was RMB 32,028,195.11, an 82.6% increase from RMB 17,545,215.84 in the same period last year[21] - Cash paid to employees in the first quarter of 2024 was RMB 144,679,166.22, a 29.4% increase from RMB 111,839,172.95 in the same period last year[21] - Net cash flow from operating activities in the first quarter of 2024 was RMB 83,437,890.69, a 43.0% increase from RMB 58,337,902.67 in the same period last year[21] - Net cash flow from investing activities in the first quarter of 2024 was negative RMB 25,342,767.51, compared to negative RMB 97,838,674.51 in the same period last year[21] - Net cash flow from financing activities in the first quarter of 2024 was RMB 29,214,704.72, a 96.0% increase from RMB 14,905,893.58 in the same period last year[21] Assets and Liabilities - Total assets as of the end of the reporting period were RMB 2.12 billion, a 4.92% increase compared to the end of the previous year[4] - Total assets as of Q1 2024 stood at 2.12 billion yuan, a 4.9% increase from 2.02 billion yuan at the end of Q1 2023[16] - Inventory increased by 6.3% to 144.62 million yuan in Q1 2024 compared to 136.03 million yuan in Q1 2023[16] - Total liabilities increased by 15.8% to 386.84 million yuan in Q1 2024 compared to 333.92 million yuan in Q1 2023[17] - Shareholders' equity grew by 2.8% to 1.74 billion yuan in Q1 2024 from 1.69 billion yuan in Q1 2023[17] - Short-term borrowings increased by 42.86% to RMB 100.09 million due to increased bank loans[8] R&D and Expenses - R&D expenses increased by 32.72% to RMB 38.07 million due to increased R&D investment[9] - R&D expenses increased by 32.7% to 38.07 million yuan in Q1 2024 compared to 28.68 million yuan in Q1 2023[18] - Sales expenses rose by 12% to 150.01 million yuan in Q1 2024 from 133.97 million yuan in Q1 2023[18] - Cost of goods sold increased by 21.4% to 83.61 million yuan in Q1 2024 compared to 68.86 million yuan in Q1 2023[17] - Income tax expenses rose by 173.19% to RMB 6.91 million due to increased profits[9] Intangible Assets and Government Subsidies - Intangible assets increased by 80.99% to RMB 141.69 million due to the transfer of development expenditures[8] - Government subsidies received during the reporting period amounted to RMB 5.03 million[6] Shareholders and Ownership - Total number of ordinary shareholders at the end of the reporting period is 15,740[11] - Liu Jidong holds the largest share at 28.60% with 35,637,700 shares[11] - China Construction Bank Corporation - Fullgoal Tianhui Selected Growth Mixed Securities Investment Fund holds 3.69% with 4,600,000 shares[11] - Basic Pension Insurance Fund 16022 holds 2.54% with 3,160,822 shares[11] - Basic Pension Insurance Fund 16021 holds 2.09% with 2,600,000 shares[11] - Hong Kong Securities Clearing Company Limited holds 2.06% with 2,571,859 shares[11] - Pan Yuhong holds 1.20% with 1,500,000 shares[11] - Gao E holds 1.19% with 1,488,200 shares[11] - China Construction Bank Corporation - China Europe Medical Health Mixed Securities Investment Fund holds 0.98% with 1,215,840 shares[11] - Fullgoal Fund - China Life Insurance Company Limited - Traditional Insurance - Fullgoal Fund China Life Shares Growth Stock Traditional Available for Sale Single Asset Management Plan holds 0.84% with 1,041,911 shares[11] Audit Status - The company's first quarter report for 2024 was not audited[22]